Heparin (CAS 9005-49-6)
See product citations (1)
Alternate Names:
[2-Deoxy-2-sulfoamino-6-O-sulfo-4-O-(2-O-sulfo-a-L-idopyranuronosyl)-a-D-glucopyranose]n
CAS Number:
9005-49-6
Molecular Weight:
1134.93
Molecular Formula:
C26H42N2O37S5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Heparin (CAS 9005-49-6) References
- Heparin-induced platelet dysfunction and cardiopulmonary bypass. | Muriithi, EW., et al. 2000. Ann Thorac Surg. 69: 1827-32. PMID: 10892931
- Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. | Bick, RL., et al. 2005. Hematol Oncol Clin North Am. 19: 1-51, v. PMID: 15639107
- Antimetastatic activities of heparins and modified heparins. Experimental evidence. | Borsig, L. 2010. Thromb Res. 125 Suppl 2: S66-71. PMID: 20434009
- Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry. | Li, G., et al. 2014. Anal Biochem. 455: 3-9. PMID: 24680753
- Chemical modification of heparin and heparosan. | Raman, K., et al. 2015. Methods Mol Biol. 1229: 31-6. PMID: 25325941
- Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants. | Shenoi, RA., et al. 2014. Sci Transl Med. 6: 260ra150. PMID: 25355700
- Old and new applications of non-anticoagulant heparin. | Cassinelli, G. and Naggi, A. 2016. Int J Cardiol. 212 Suppl 1: S14-21. PMID: 27264866
- Qualitative and quantitative analysis of heparin and low molecular weight heparins using size exclusion chromatography with multiple angle laser scattering/refractive index and inductively coupled plasma/mass spectrometry detectors. | Ouyang, Y., et al. 2017. J Chromatogr A. 1522: 56-61. PMID: 28958760
- Heparin concentration in cell salvage during heparinization: a pilot study. | Tamura, T., et al. 2020. Nagoya J Med Sci. 82: 449-455. PMID: 33132429
- New data on the pharmacology of heparin and low molecular weight heparins. | Samama, MM., et al. 1996. Drugs. 52 Suppl 7: 8-14; discussion 14-5. PMID: 9042555
Inhibitor of:
α-actinin-1, β thromboglobulin, Acrosin, alpha-L-iduronidase, Arylsulfatase B, Arylsulfatase J, Baculovirus gp64, C4b, casein kinase IIβ, CHST5, CHST6, CLEC-4E, creatine kinase-M, DDX10, DDX19B, DIC, DSCAML1, EXT2, Factor IX, Factor V, Factor VIII, Factor XII, Factor XIII A, Fibrinogen β, FucT-l, FVT1, GPC3, HABP2, HAI-1, hCG_38480, HDGF, hnRNP F, HPSE2_Hpse2, HRG-α, HS3ST6, ILT-8, IP3KB, ITF, MAG, MDGA1, MK, NCAG1, neurocan, Neuroplastin, Occludin, Olfr393, Olfr508, Olr1514, OTTMUSG00000019145, PF-4, PN-1, Protamine 1, Protamine 2, Protein C, PTN, RACK1, SerpinB11, SOD-3, Stabilin-1, STRO-1, Sulf-2, Syndecan-3, T2-cadherin, TFPI-2, Thrombospondin 5, and ZNHIT2.Activator of:
β-FR, 9G8, ADAM22, ADAM25, ADAMTS-15, ADAMTS-16, ADAMTS-17, Aldosterone, Annexin II, apoC-III, bomapin, Bride of Sevenless, C1INH, CCBE1, CHST7, Cks2, Cnpy1, Connexin 43, Contactin 5, CRIM1, D-Dimer, DNase I, Dpl, Dppa1, EG619597, EGF, Endoglycan, Esophagin, Factor X, FARP2, FGF-1, FGF-2, FGF-20, FGF-6, FGF-7, FGF-8, FGF-BP, Fibulin-5, FOXC1, gC1q-R/p32, GDF-5, GDF-6, GLCE, glypican-2, glypican-5, GPC3, HCII, Hirudin, HS2ST1, HS3ST6, HYAL1, Integrin α7, Integrin βId, Kininogen, KLK6, Laminin β-1, Laminin β-2, LIMK-2, LOH11CR2A, LSm1, MACC1, MARCH9, MMP-8, MPZL2, MT-MMP-1, MT-MMP-4, Mucin 4, NCAG1, NDST1, NDV HN, Neu, NgBR, OTTMUSG00000019145, PLA2R, plasma kallikrein, PLGLB1, PLGLB2, PNAd, PRAS40, PRL-3, Proliferin, PRSSL1, PSG1, RGMa, Riboflavin kinase, RNA pol α, Rpp20, SEC24A, SerpinA3k, SerpinB8, SNRNP48, SPINT4, Sulf-1, Syndecan-1, Syndecan-2, Syndecan-4, TAFI, TATDN2, TESP3, Thrombin R, Thrombospondin 1, Trypsin-3, twisted gastrulation, UPII, UTP23, WAVE3, and ZNF771.Substrate of:
NAGLU.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Heparin, 25 mg | sc-507344 | 25 mg | $119.00 |